Distributors and Janssen/J&J Settlements
Tennessee has joined a broad coalition of states and subdivisions in reaching a $26 billion settlement with four companies to resolve legal claims for their role in the opioid crisis. Tennessee’s share of the settlement funds is expected to exceed $600 million over 18 years. The settlement consists of two agreements. One agreement is with the three major pharmaceutical distributors: AmerisourceBergen, Cardinal Health, and McKesson. The second agreement is with an opioid manufacturer: Janssen, a subsidiary of Johnson & Johnson.
To become effective, a critical mass of states and political subdivisions must agree to participate in the settlements. Tennessee has joined a substantial majority of states in agreeing to participate and the companies have determined that there is sufficient state joinder to move forward with the subdivision sign-on period. Subdivisions will have until January 2, 2022 to become initial participating subdivisions.
Over the next few weeks, notices and other materials will be sent out and posted online. This website will be updated with additional information regarding the allocation of funds within Tennessee and the process for counties and cities to join the settlement.
Settlement Documents and Related Materials
- Attorney General Slatery Leads $26 Billion Agreement with Opioid Distributors/Manufacturer (July 21, 2021)
- Distributor Settlement Agreement (September 18, 2021)
- Janssen/J&J Settlement Agreement (July 30, 2021)
- In anticipation of these settlements, the General Assembly passed legislation earlier this year that addresses certain settlement funds that are committed to abating the opioid crisis. The legislation, which was signed by Governor Bill Lee, includes provisions creating an Opioid Abatement Trust Fund and Opioid Abatement Council: Public Chapter 0491